10月27日,West Pharmaceutical Services, Inc.(WST.US)公布财报,公告显示公司2024财年第三财季净利润为1.36亿美元,同比减少15.53%;其中营业收入为7.47亿美元,同比减少0.13%,每股基本收益为1.87美元。从资产负债表来看,West Pharmaceutical Services, Inc.(WST.US)总负债9.23亿美元,其中短期债务...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.